100 related articles for article (PubMed ID: 2711930)
21. Biosynthesis of platelet-activating factor (PAF)acether). III. Formation of PAF-acether from synthetic substrates by stimulated murine macrophages.
Mencia-Huerta JM; Roubin R; Morgat JL; Benveniste J
J Immunol; 1982 Aug; 129(2):804-8. PubMed ID: 7086143
[TBL] [Abstract][Full Text] [Related]
22. Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite.
Touqui L; Jacquemin C; Vargaftig BB
Biochem Biophys Res Commun; 1983 Feb; 110(3):890-3. PubMed ID: 6838557
[TBL] [Abstract][Full Text] [Related]
23. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
[TBL] [Abstract][Full Text] [Related]
24. Lyso-PAF analogues and lysophosphatidylcholines from the marine sponge Spirastrella abata as inhibitors of cholesterol biosynthesis.
Shin BA; Kim YR; Lee IS; Sung CK; Hong J; Sim CJ; Im KS; Jung JH
J Nat Prod; 1999 Nov; 62(11):1554-7. PubMed ID: 10579872
[TBL] [Abstract][Full Text] [Related]
25. Possible origins of PAF-acether and lyso-PAF-acether in rat lung alveoli secondary to hypoxia.
Prévost MC; Cariven C; Chap H
Biochim Biophys Acta; 1988 Oct; 962(3):354-61. PubMed ID: 3167085
[TBL] [Abstract][Full Text] [Related]
26. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
Sakamoto T; Elwood W; Barnes PJ; Chung KF
J Appl Physiol (1985); 1993 Mar; 74(3):1117-22. PubMed ID: 8482649
[TBL] [Abstract][Full Text] [Related]
27. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
Keraly CL; Benveniste J
Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
[TBL] [Abstract][Full Text] [Related]
28. Biosynthesis of platelet-activating factor (PAF) in human polymorphonuclear leucocytes. The role of lyso-PAF disposal and free arachidonic acid.
Garcia MC; Fernandez-Gallardo S; Gijon MA; Garcia C; Nieto ML; Sanchez Crespo M
Biochem J; 1990 May; 268(1):91-8. PubMed ID: 1693077
[TBL] [Abstract][Full Text] [Related]
29. Effect of structural analogues of PAF-acether on platelet desensitization.
Keraly CL; Coëffier E; Tencé M; Borrel MC; Benveniste J
Br J Haematol; 1983 Mar; 53(3):513-21. PubMed ID: 6824590
[TBL] [Abstract][Full Text] [Related]
30. Platelet-activating factor (PAF)-like phospholipids formed during peroxidation of phosphatidylcholines from different foodstuffs.
Tanaka T; Tokumura A; Tsukatani H
Biosci Biotechnol Biochem; 1995 Aug; 59(8):1389-93. PubMed ID: 7549088
[TBL] [Abstract][Full Text] [Related]
31. The release of lyso-PAF from guinea-pig lungs.
Parente L; Fitzgerald M; De Nucci G; Moncada S
Eur J Pharmacol; 1985 Jun; 112(2):281-4. PubMed ID: 4029263
[TBL] [Abstract][Full Text] [Related]
32. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
[TBL] [Abstract][Full Text] [Related]
33. CD2 triggering stimulates the formation of platelet-activating factor-acether from alkyl-arachidonoyl-glycerophosphocholine in a human CD4+ T lymphocyte clone.
Le Gouvello S; Vivier E; Debre P; Thomas Y; Colard O
J Immunol; 1992 Aug; 149(4):1289-93. PubMed ID: 1354232
[TBL] [Abstract][Full Text] [Related]
34. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
Touqui L; Jacquemin C; Dumarey C; Vargaftig BB
Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037
[TBL] [Abstract][Full Text] [Related]
35. The metabolism of platelet-activating factor in severe and cerebral malaria.
Davis TM; Binh TQ; van Phuong N; Sturm M; St John A; Dyer JR; Anh TK
J Infect; 1995 Nov; 31(3):181-8. PubMed ID: 8586836
[TBL] [Abstract][Full Text] [Related]
36. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
37. The lyso-precursor of platelet-activating factor (lyso-PAF) in ischaemic myocardium.
Leong L; Sturm M; Taylor R
J Lipid Mediat; 1991 Nov; 4(3):277-87. PubMed ID: 1764576
[TBL] [Abstract][Full Text] [Related]
38. PAF-acether in chronic arthritis.
Pettipher ER; Higgs GA; Henderson B
Agents Actions; 1987 Jun; 21(1-2):98-103. PubMed ID: 3630862
[TBL] [Abstract][Full Text] [Related]
39. Metabolism of platelet-activating factor in primary cultured adult rat hepatocytes by a new pathway involving phospholipase C and alkyl monooxygenase.
Okayasu T; Hoshii K; Seyama K; Ishibashi T; Imai Y
Biochim Biophys Acta; 1986 Mar; 876(1):58-64. PubMed ID: 3947669
[TBL] [Abstract][Full Text] [Related]
40. Interdigitation of bilayers from ether lipid analogs: (R)-PAF, (R)-Lyso-PAF and the antineoplastic (R)-ET-18-OMe.
Xie X; Lin S; Moring J; Makriyannis A
Biochim Biophys Acta; 1996 Aug; 1283(1):111-8. PubMed ID: 8765102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
